{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:58:56Z","timestamp":1760057936708,"version":"build-2065373602"},"reference-count":23,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Korea Health Technology R&amp;D Project","award":["RS-2022-KH129464","RS-2020-KH095267"],"award-info":[{"award-number":["RS-2022-KH129464","RS-2020-KH095267"]}]},{"name":"Patient-Centered Clinical Research Coordinating Center","award":["RS-2022-KH129464","RS-2020-KH095267"],"award-info":[{"award-number":["RS-2022-KH129464","RS-2020-KH095267"]}]},{"name":"Hallym University Research Fund","award":["RS-2022-KH129464","RS-2020-KH095267"],"award-info":[{"award-number":["RS-2022-KH129464","RS-2020-KH095267"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Functional iron-deficiency anemia (FIDA) is a side effect of many cancer treatments, occurring when chemotherapy drugs damage bone marrow cells, which are responsible for producing red blood cells, due to the myelosuppressive effects of chemotherapy, or to the cancer itself. This study was performed to compare the effects of darbepoetin alfa alone, or in combination with ferric derisomaltose in cancer patients with FIDA, and to elucidate the mechanism underlying the effects in F36E cells. F36E cells treated with darbepoetin alfa showed increased cell viability. AML and GC cells treated with darbepoetin alfa, ferric derisomaltose, or ferric derisomaltose plus darbepoetin alfa showed no induction of apoptosis. The effects of these drugs on the anticancer efficacy of PTX chemotherapy were examined by analyzing cell viability and induction of apoptosis. Darbepoetin alfa, ferric derisomaltose, and ferric derisomaltose plus darbepoetin alfa showed no significant inhibitory effects on the apoptosis-inducing activity of PTX in GC cell lines. Patients with chemotherapy-induced FIDA in Group I receiving ferric derisomaltose plus darbepoetin alfa showed higher hemoglobin levels, transferrin saturation, and ferritin levels compared to those in Group II, treated with darbepoetin alfa alone. In cancer patients with FIDA, the prognosis of anemia treatment was better in the ferric derisomaltose plus darbepoetin alfa combination group than in the group receiving darbepoetin alfa monotherapy.<\/jats:p>","DOI":"10.3390\/ijms26052203","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T10:12:33Z","timestamp":1740737553000},"page":"2203","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Darbepoetin Alfa and Ferric Derisomaltose Plus Darbepoetin Alfa in Functional Iron-Deficiency Anemia"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8836-5490","authenticated-orcid":false,"given":"Sung-Hwa","family":"Sohn","sequence":"first","affiliation":[{"name":"Hallym Translational Research Institute, College of Medicine, Hallym University, Anyang-si 14068, Gyeonggi-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heejung","family":"Sul","sequence":"additional","affiliation":[{"name":"Hallym Translational Research Institute, College of Medicine, Hallym University, Anyang-si 14068, Gyeonggi-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2360-5160","authenticated-orcid":false,"given":"Bumjun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hallym University Medical Center, College of Medicine, Hallym University, Anyang-si 14068, Gyeonggi-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daeyoung","family":"Zang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hallym University Medical Center, College of Medicine, Hallym University, Anyang-si 14068, Gyeonggi-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/annonc\/mdh235","article-title":"The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: Results from five randomized clinical trials","volume":"15","author":"Cella","year":"2004","journal-title":"Ann. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.ejca.2004.06.019","article-title":"The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients","volume":"40","author":"Ludwig","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/jnci\/91.19.1616","article-title":"Chemotherapy-induced anemia in adults: Incidence and treatment","volume":"91","author":"Groopman","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Mhaskar, R., Wao, H., Miladinovic, B., Kumar, A., and Djulbegovic, B. (2016). The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. Cochrane Database Syst. Rev., 2.","DOI":"10.1002\/14651858.CD009624.pub2"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.rmr.2014.10.734","article-title":"Management of chemotherapy-induced anemia in lung cancer","volume":"32","author":"Tiotiu","year":"2015","journal-title":"Rev. Mal. Respir."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Aapro, M., Beguin, Y., Bokemeyer, C., Dicato, M., Gascon, P., Glaspy, J., Hofmann, A., Link, H., Littlewood, T., and Ludwig, H. (2018). Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. Ann. Oncol., 29.","DOI":"10.1093\/annonc\/mdy323"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0301-472X(03)00006-7","article-title":"Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin","volume":"31","author":"Egrie","year":"2003","journal-title":"Exp. Hematol."},{"key":"ref_8","first-page":"399","article-title":"The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: A review","volume":"60","author":"Qunibi","year":"2010","journal-title":"Arzneimittelforschung"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/annonc\/mds338","article-title":"Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia","volume":"24","author":"Steinmetz","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00520-015-2728-3","article-title":"Clinical use of ferric carboxymaltose in patients with solid tumours or haematological malignancies in France","volume":"24","author":"Toledano","year":"2016","journal-title":"Support Care Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1345\/aph.1A416","article-title":"Darbepoetin alfa: A novel erythropoiesis-stimulating protein","volume":"36","author":"Joy","year":"2002","journal-title":"Ann. Pharmacother."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0301-472X(01)00723-8","article-title":"Novel erythropoiesis stimulating protein (darbepoetin alfa) alleviates anemia associated with chronic inflammatory disease in a rodent model","volume":"29","author":"Coccia","year":"2001","journal-title":"Exp. Hematol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Miller, J.L. (2013). Iron deficiency anemia: A common and curable disease. Cold Spring Harb. Perspect. Med., 3.","DOI":"10.1101\/cshperspect.a011866"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ajh.26124","article-title":"Intravenous ferric derisomaltose for the treatment of iron deficiency anemia","volume":"96","author":"Auerbach","year":"2021","journal-title":"Am. J. Hematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1084\/jem.20122760","article-title":"Erythropoietin: Multiple targets, actions, and modifying influences for biological and clinical consideration","volume":"210","author":"Broxmeyer","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ueda, N., and Takasawa, K. (2018). Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease. Nutrients, 10.","DOI":"10.3390\/nu10091173"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1200\/JCO.2006.10.4620","article-title":"Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia","volume":"26","author":"Bastit","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.leu.2404562","article-title":"Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: A randomized multicenter study","volume":"21","author":"Hedenus","year":"2007","journal-title":"Leukemia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.2004.08.119","article-title":"Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: A multicenter, open-label, randomized trial","volume":"22","author":"Auerbach","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1182\/blood-2007-07-102848","article-title":"Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2","volume":"111","author":"Grebien","year":"2008","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0092-8674(93)90414-L","article-title":"JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin","volume":"74","author":"Witthuhn","year":"1993","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/03007995.2018.1560134","article-title":"Efficacy and safety of CKD-11101 (darbepoetin-alfa proposed biosimilar) compared with NESP in anaemic chronic kidney disease patients not on dialysis","volume":"35","author":"Lee","year":"2019","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Skopek, R., Palusinska, M., Kaczor-Keller, K., Pingwara, R., Papierniak-Wygladala, A., Schenk, T., Lewicki, S., Zelent, A., and Szymanski, L. (2023). Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065377"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/5\/2203\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:44:49Z","timestamp":1760028289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/5\/2203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["ijms26052203"],"URL":"https:\/\/doi.org\/10.3390\/ijms26052203","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2025,2,28]]}}}